Although breast cancer incidence is higher overall in women of European descent than in women of African ancestry, African-American (AA) women are more likely than European-American (EA) women to be diagnosed before age 40 and to have breast tumors with more aggressive features, including high-grade and negative estrogen receptor (ER) status (reviewed in [1]). The gene discussed is ESR1; the disease is breast carcinoma.